
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
April in the nation's capital city is a time of flowering: public spaces filled with daffodils and tulips, trees bursting into blossom. Most years, optimism flowers along with the trees.






